FundedIQ
Biotechnology

AWAK Technologies: Funding, Investors & Team (Oct 2026)

AWAK Technologies is a company that specializes in the development of wearable dialysis machines. These machines are lightweight, weighing only 1kg, and are powered by batteries, allowing for continuous dialysis. The company received certification in September 2008 for its ISO 13485 Quality Management System, which recognizes its ability to design, manufacture, and distribute medical devices. The technology behind their product, known as the Automated Wearable Artificial Kidney (AWAK), is based on tidal peritoneal dialysis and was researched by Profs David Lee & Martin Roberts of UCLA and VA Systems. The engineering and development of the AWAK machine is conducted in Singapore in collaboration with Temasek Polytechnic. Currently, the company has completed its research and development phase and is in the clinical trial stage, aiming to obtain both FDA and CE certifications. The AWAK Regular Cartridge, which is a component of the wearable artificial kidney, is currently in the pilot production stage and is expected to undergo clinical trials by the end of 2012. This innovative device operates continuously and mimics the function of a normal kidney. Its small size, light weight, and battery-operated design allow patients to maintain their daily routines without restriction, including work, travel, and leisure activities.

www.awak.com LinkedIn Burbank, United States 51-100 employees
Biotechnology Wearables B2B
Total raised
$20.0M
Rounds
1
Latest
Series B
Sep 2023

AWAK Technologies has raised $20.0M across 1 funding round on record, the most recent a Series B of $20.0M announced in Sep 2023.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

AWAK Technologies Company Profile and Key Stats

Total funding raised
$20.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$20.0M in Sep 2023
Employees
51-100
reported band
Headquarters
Burbank, United States

Latest funding round on record: Sep 2023.

AWAK Technologies Funding Rounds

Date
Round
Amount
Series B
$20.0M

AWAK Technologies Founders and Leadership Team

Name
Role
Contact
Neo Kok Beng
CEO
—

No contact details are on record for this team yet.

AWAK Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
4,401
$31M

AWAK Technologies' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like AWAK Technologies in Biotechnology and Burbank

Companies Similar to AWAK Technologies

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

AWAK Technologies Funding FAQs

What does AWAK Technologies do?

AWAK Technologies is a company that specializes in the development of wearable dialysis machines. These machines are lightweight, weighing only 1kg, and are powered by batteries, allowing for continuous dialysis. The company received certification in September 2008 for its ISO 13485 Quality Management System, which recognizes its ability to design, manufacture, and distribute medical devices. The technology behind their product, known as the Automated Wearable Artificial Kidney (AWAK), is based on tidal peritoneal dialysis and was researched by Profs David Lee & Martin Roberts of UCLA and VA Systems. The engineering and development of the AWAK machine is conducted in Singapore in collaboration with Temasek Polytechnic. Currently, the company has completed its research and development phase and is in the clinical trial stage, aiming to obtain both FDA and CE certifications. The AWAK Regular Cartridge, which is a component of the wearable artificial kidney, is currently in the pilot production stage and is expected to undergo clinical trials by the end of 2012. This innovative device operates continuously and mimics the function of a normal kidney. Its small size, light weight, and battery-operated design allow patients to maintain their daily routines without restriction, including work, travel, and leisure activities.

How much funding has AWAK Technologies raised?

AWAK Technologies has raised $20.0M across 1 round on record. The most recent is a Series B of $20.0M announced in Sep 2023.

When did AWAK Technologies last raise funding?

AWAK Technologies' most recent funding round on record is a Series B of $20.0M, announced in Sep 2023.

Who is the CEO of AWAK Technologies?

Neo Kok Beng is listed as CEO at AWAK Technologies.

Where is AWAK Technologies headquartered?

AWAK Technologies is based in Burbank, California, United States.

How many employees does AWAK Technologies have?

AWAK Technologies is in the 51-100 employee band.

How does AWAK Technologies' funding compare to other Biotechnology startups?

AWAK Technologies' latest round of $20.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's AWAK Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AWAK Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.